SAB Biotherapeutics Ownership | Who Owns SAB Biotherapeutics?


OverviewForecastRevenueFinancialsChart

SAB Biotherapeutics Ownership Summary


SAB Biotherapeutics is owned by 20.70% institutional investors, 18.76% insiders, and 60.54% retail investors. Bvf inc/il is the largest institutional shareholder, holding 9.88% of SABS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.45% of its assets in SAB Biotherapeutics shares.

SABS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSAB Biotherapeutics20.70%18.76%60.54%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bvf inc/il917.83K9.88%$1.61M
Sessa capital im458.46K4.93%$804.59K
Kovitz investment group partners19.20K0.21%$33.70K
First premier bank18.99K0.20%$33.00K
Blackrock funding, inc. /de7.01K0.08%$12.30K
Sachetta4.10K0.04%$7.20K
Mai capital management217.000.00%$381.00
Gs investments200.000.00%$351.00
Raymond james financial45.000.00%$79.00
Harbour investments50.000.00%$88.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bvf inc/il917.83K0.06%$1.61M
Sessa capital im458.46K0.02%$804.59K
First premier bank18.99K0.01%$33.00K
Sachetta4.10K0.00%$7.20K
Gs investments200.000.00%$351.00
Kovitz investment group partners19.20K0.00%$33.70K
Blackrock funding, inc. /de7.01K-$12.30K
Raymond james financial45.00-$79.00
Harbour investments50.00-$88.00
Mai capital management217.00-$381.00

Top Buyers

HolderShares% AssetsChange
Raymond james financial45.00-45.00
First premier bank18.99K0.01%-
Mai capital management217.00--
Sessa capital im458.46K0.02%-
Harbour investments50.00--

Top Sellers

HolderShares% AssetsChange
Hb wealth management---263.20K
Silver oak securities---20.19K
Xtx topco---16.55K
Blackrock funding, inc. /de7.01K--15.29K
First premier bank18.99K0.01%-

New Positions

HolderShares% AssetsChangeValue
Raymond james financial45.00-45.00$79.00

Sold Out

HolderChange
Xtx topco-16.55K
Silver oak securities-20.19K
Hb wealth management-263.20K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202525-3.85%1,923,784-12.93%203.66%9-18.18%4-33.33%
Mar 31, 2025264.00%2,209,552-15.93%232.95%1122.22%6-14.29%
Dec 31, 2024254.17%2,628,252-16.34%282.46%928.57%775.00%
Sep 30, 20242414.29%3,141,7360.47%332.97%7-4-
Jun 30, 202421-8.70%3,127,151-6.36%332.59%740.00%4-77.78%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv227.59K2.45%-4.97K
Vanguard Institutional Extnd Mkt Idx Tr51.43K0.55%2.76K
Fidelity Extended Market Index43.44K0.47%-113.00
Fidelity Total Market Index12.90K0.14%-
Fidelity Series Total Market Index10.62K0.11%-
Spartan Extended Market Index Pool F8.87K0.10%-
NT Ext Equity Mkt Idx Fd - L8.64K0.09%-
Northern Trust Extended Eq Market Idx8.64K0.09%-
Spartan Extended Market Index Pool E8.36K0.09%356.00
Fidelity Nasdaq Composite Index4.94K0.05%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 07, 2023Sullivan Eddie Joe Chief Executive OfficerBuy$1.53K
Nov 30, 2023King Michael CHIEF FINANCIAL OFFICERBuy$4.50K
Nov 29, 2023Reich Samuel J Executive ChairmanBuy$9.84K
Sep 13, 2022HAMILTON CHRISTINE E Buy$7.30K
Sep 07, 2022Sullivan Eddie Joe CHIEF EXECUTIVE OFFICERBuy$10.32K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--

SABS Ownership FAQ


Who Owns SAB Biotherapeutics?

SAB Biotherapeutics shareholders are primarily institutional investors at 20.70%, followed by 18.76% insiders and 60.54% retail investors. The average institutional ownership in SAB Biotherapeutics's industry, Biotech Stocks , is 306.59%, which SAB Biotherapeutics falls below.

Who owns the most shares of SAB Biotherapeutics?

SAB Biotherapeutics’s largest shareholders are Bvf inc/il (917.83K shares, 9.88%), Sessa capital im (458.46K shares, 4.93%), and Kovitz investment group partners (19.2K shares, 0.21%). Together, they hold 15.01% of SAB Biotherapeutics’s total shares outstanding.

Does Blackrock own SAB Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of SAB Biotherapeutics.

Who is SAB Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Bvf inc/il is SAB Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 0.06% of its assets in 917.83K SAB Biotherapeutics shares, valued at 1.61M$.

Who is the top mutual fund holder of SAB Biotherapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of SAB Biotherapeutics shares, with 2.45% of its total shares outstanding invested in 227.59K SAB Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools